Pravir Kumar

发表

Role of Wnt-p53-Nox signaling pathway in cancer development and progression.

Dhiraj Kumar, Sakshi Sharma, S. Verma, 2015 .

Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders.

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2020, Life sciences.

Histone deacetylase in neuropathology.

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2021, Advances in clinical chemistry.

p38 MAPK and PI3K/AKT Signalling Cascades inParkinson’s Disease

N. Jha, Pravir Kumar, R. K. Ambasta, 2015, International journal of molecular and cellular medicine.

Identification of novel class I and class IIb histone deacetylase inhibitor for Alzheimer's disease therapeutics.

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2020, Life sciences.

Mutational Consequences of Aberrant Ion Channels in Neurological Disorders

Dhiraj Kumar, Pravir Kumar, R. K. Ambasta, 2014, The Journal of Membrane Biology.

Integrated Mechanism of Lysine 351, PARK2, and STUB1 in AβPP Ubiquitination.

Dhiraj Kumar, Pravir Kumar, 2019, Journal of Alzheimer's disease : JAD.

Parkin reverses intracellular β‐amyloid accumulation and its negative effects on proteasome function

C. Moussa, Han-Kyu Lee, H. Querfurth, 2010, Journal of neuroscience research.

Role of Wnt-p 53-Nox Signaling Pathway in Cancer Development and Progression

Dhiraj Kumar, Sakshi Sharma, S. Verma, 2015 .

The Insulin/Akt Signaling Pathway Is Targeted by Intracellular -Amyloid

Han-Kyu Lee, H. Querfurth, Pravir Kumar, 2009 .

VEGF/CDK2 are involved in diabetic organ regeneration.

Krishna A. Adeshara, Pravir Kumar, R. K. Ambasta, 2020, Biochemical and biophysical research communications.

Re-expression of cell cycle markers in aged neurons and muscles: Whether cells should divide or die?

N. Jha, Dhiraj Kumar, Pravir Kumar, 2017, Biochimica et biophysica acta. Molecular basis of disease.

Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder

Pravir Kumar, R. K. Ambasta, Harleen Kohli, 2017, Journal of Translational Medicine.

Comparative study of anti-angiogenic activities of luteolin, lectin and lupeol biomolecules

N. Jha, Dhiraj Kumar, Pravir Kumar, 2015, Journal of Translational Medicine.

Cross talk mechanism of disturbed sleep patterns in neurological and psychological disorders

Pravir Kumar, R. K. Ambasta, S. K. Jha, 2022, Neuroscience & Biobehavioral Reviews.

An integrated approach to unravel a putative crosstalk network in Alzheimer’s disease and Parkinson’s disease

Pravir Kumar, R. K. Ambasta, Indu Bisht, 2020, Neuropeptides.

Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration.

N. Jha, Dhiraj Kumar, Pravir Kumar, 2017, Biochimica et biophysica acta. Molecular basis of disease.

Clinical management of lipid profile, renal and liver function versus HbA1c profile in diabetes affected patients of Vellore, Tamil Nadu, India

Archita Sharma, Pravir Kumar, R. K. Ambasta, 2012 .

Transgenic expression of B‐APP in fast‐twitch skeletal muscle leads to calcium dyshomeostasis and IBM‐like pathology

Pravir Kumar, F. LaFerla, K. Walsh, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Protein S-sulfhydration: Unraveling the prospective of hydrogen sulfide in the brain, vasculature and neurological manifestations

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2022, Ageing Research Reviews.

Multipotent mesenchymal stromal cells (MSCs): An overview

Pravir Kumar, R. K. Ambasta, H. Shah, 2011 .

Protective effect of transplanted bone marrow mononuclearcells (BMMNCs) in organ damage caused due to streptozotocin (STZ) induced diabetes

Pravir Kumar, R. K. Ambasta, A. Arivarasan, 2012 .

Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach

Pravir Kumar, Dia Advani, 2022, Neuropeptides.

Free radical biology in neurological manifestations: mechanisms to therapeutics interventions

Pravir Kumar, R. K. Ambasta, Devesh Srivastava, 2021, Environmental Science and Pollution Research.

COLLABORATIVE ACTION OF CELL CYCLE, MOLECULAR CHAPERONES, AND UBIQUITIN PROTEASOME SYSTEM IN NEUROONCOLOGY

Pravir Kumar, R. K. Ambasta, P. B. Sharma, 2013 .

Unboxing the molecular modalities of mutagens in cancer

Pravir Kumar, R. K. Ambasta, S. Kumari, 2021, Environmental Science and Pollution Research.

Why our heart is not prone to cancer

Pravir Kumar, R. K. Ambasta, Paresh Sharma, 2013 .

Naringenin and quercetin reverse the effect of hypobaric hypoxia and elicit neuroprotective response in the murine model

Pravir Kumar, R. K. Ambasta, K. Anand, 2012, Brain Research.

Quantum dots: The cutting-edge nanotheranostics in brain cancer management.

B. Mukherjee, R. Kandimalla, S. Ojha, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Putative micro-RNAs in the pathogenesis of Alzheimer's diseases

Navneet, Pravir Kumar, 2022, 2022 8th International Conference on Advanced Computing and Communication Systems (ICACCS).

Modified benzoxazolone (ABO‐AA) based single photon emission computed tomography (SPECT) probes for 18 kDa translocator protein

Pravir Kumar, A. Tiwari, P. Srivastava, 2019, Drug development research.

Mutational Consequences of Aberrant Ion Channels in Neurological Disorders

Dhiraj Kumar, Pravir Kumar, R. K. Ambasta, 2014, The Journal of Membrane Biology.

Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2023, Ageing Research Reviews.

Epigenetic Post transcriptional Mutation in Neuro-Oncology

Pravir Kumar, R. K. Ambasta, Renubala Sharma, 2016 .

Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?

Saurabh Kumar Jha, Niraj Kumar Jha, Pravir Kumar, 2017, Journal of Alzheimer's disease : JAD.

Combinatorial Antitumor Effect of Naringenin and Curcumin Elicit Angioinhibitory Activities In Vivo

Pravir Kumar, R. K. Ambasta, Anup Kumar, 2012, Nutrition and cancer.

Cellular Toxicity of Mesoporous Silica Nanoparticle in SHSY5Y and BMMNCs Cell.

Geetha Manivasagam, Pravir Kumar, R. K. Ambasta, 2019, Pharmaceutical nanotechnology.

CREB1K292 and HINFPK330 as Putative Common Therapeutic Targets in Alzheimer’s and Parkinson’s Disease

Pravir Kumar, Rohan Gupta, 2021, ACS omega.

Direct Interaction of the Novel Nox Proteins with p22phox Is Required for the Formation of a Functionally Active NADPH Oxidase*

Pravir Kumar, R. Busse, R. Brandes, 2004, Journal of Biological Chemistry.

Decoding the Role of MDM2 as a Potential Ubiquitin E3 Ligase and Identifying the Therapeutic Efficiency of Alkaloids against MDM2 in Combating Glioblastoma

Pravir Kumar, Sudhanshu Sharma, 2023, ACS omega.

Mitochondrial dysfunction in metabolic disorders

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2021, Mitochondrial Dysfunction and Nanotherapeutics.

Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.

N. Jha, Dhiraj Kumar, Pravir Kumar, 2015, Journal of Alzheimer's disease : JAD.

Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2020, Neurochemistry International.

Hypoxia-Induced Signaling Activation in Neurodegenerative Diseases: Targets for New Therapeutic Strategies.

N. Jha, Dhiraj Kumar, Pravir Kumar, 2018, Journal of Alzheimer's disease : JAD.

Regulatory mechanism of cyclins and cyclin-dependent kinases in post-mitotic neuronal cell division.

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2021, Life sciences.

Artificial intelligence to deep learning: machine intelligence approach for drug discovery

Pravir Kumar, R. K. Ambasta, Devesh Srivastava, 2021, Molecular Diversity.

Combinatorial therapy in tumor microenvironment: Where do we stand?

Pravir Kumar, R. K. Ambasta, S. Kumari, 2021, Biochimica et biophysica acta. Reviews on cancer.

Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.

N. Jha, Pravir Kumar, R. K. Ambasta, 2014, Journal of Alzheimer's disease : JAD.

Epigenetics and Angiogenesis in Cancer

Satyaprakash, N. Jha, Pravir Kumar, 2016 .

Mitochondrial dysfunction and autophagy in neurodegeneration

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2021, Mitochondrial Dysfunction and Nanotherapeutics.

Post-translational modifications: Regulators of neurodegenerative proteinopathies

Pravir Kumar, R. K. Ambasta, Devesh Srivastava, 2021, Ageing Research Reviews.

Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy

Archita Sharma, Pravir Kumar, R. K. Ambasta, 2011, Vascular cell.

Cross‐functional E3 ligases Parkin and C‐terminus Hsp70‐interacting protein in neurodegenerative disorders

H. Querfurth, Pravir Kumar, R. K. Ambasta, 2012, Journal of neurochemistry.

Multifaced role of protein deacetylase sirtuins in neurodegenerative disease

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2021, Neuroscience & Biobehavioral Reviews.

Tomato Heat Stress Transcription Factor HsfB1 Represents a Novel Type of General Transcription Coactivator with a Histone-Like Motif Interacting with the Plant CREB Binding Protein Ortholog HAC1

E. Treuter, Pascal von Koskull-Döring, Pravir Kumar, 2004, The Plant Cell Online.

Differential Effects of Mitochondrial Heat Shock Protein 60 and Related Molecular Chaperones to Prevent Intracellular β-Amyloid-induced Inhibition of Complex IV and Limit Apoptosis*

H. Querfurth, Pravir Kumar, R. Mestril, 2006, Journal of Biological Chemistry.

Microbial carotenoid production and their potential applications as antioxidants: A current update

Pravir Kumar, Khyati Y. Joshi, R. Kataria, 2023, Process Biochemistry.

Epigenesis in Colorectal Cancer: A Lethal Change in the Cell

Dhiraj Kumar, Pravir Kumar, R. K. Ambasta, 2016 .

Obesity and Neurodegeneration

Pravir Kumar, R. K. Ambasta, Rajat M. Gupta, 2015 .

The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid.

Pravir Kumar, Han-Kyu Lee, H. Querfurth, 2009, Molecular biology of the cell.

Pharmacological relevance of CDK inhibitors in Alzheimer's disease

Pravir Kumar, Rohan Gupta, Nishtha Malhotra, 2021, Neurochemistry International.

Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma Multiforme

Pravir Kumar, Smita Kumari, 2023, ACS omega.

An In-Silico Investigation of Key Lysine Residues and Their Selection for Clearing off Aβ and Holo-AβPP Through Ubiquitination

Dhiraj Kumar, Pravir Kumar, 2018, Interdisciplinary Sciences: Computational Life Sciences.

Pharmacological intervention in oxidative stress as a therapeutic target in neurological disorders.

Pravir Kumar, R. K. Ambasta, Nishtha Malhotra, 2021, The Journal of pharmacy and pharmacology.

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics

Hari Prasad Devkota, M. Kamal, S. Ojha, 2021, Journal of advanced research.

CHIP and HSPs interact with β-APP in a proteasome-dependent manner and influence Aβ metabolism

K. Kosik, C. Patterson, H. Band, 2007 .

CHIP and HSPs interact with beta-APP in a proteasome-dependent manner and influence Abeta metabolism.

K. Kosik, C. Patterson, H. Band, 2007, Human molecular genetics.

Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies

Dhiraj Kumar, Pravir Kumar, R. K. Ambasta, 2020, Ageing Research Reviews.

Role of oxidative stress, ER stress and ubiquitin proteasome system in neurodegeneration

N. Jha, Pravir Kumar, R. K. Ambasta, 2014 .

Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer’s Disease: Using the Multiomics Approach

Pravir Kumar, Dia Advani, 2021, ACS omega.

Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis.

K. Walsh, Ling Zeng, Han-Kyu Lee, 2014, Human molecular genetics.

Synergy of bone marrow transplantation and curcumin ensue protective effects at early onset of diabetes in mice 在早期发病的糖尿病小鼠中使用骨髓移植和姜黄素联合治疗具有协同保护作用

Pravir Kumar, R. K. Ambasta, S. Yadav, 2015, Journal of diabetes.

Cancer Fighting SiRNA-RRM2 loaded nanorobots.

Pravir Kumar, R. K. Ambasta, Arjun Sharma, 2020, Pharmaceutical nanotechnology.

Can luteolin be a therapeutic molecule for both colon cancer and diabetes?

Dhiraj Kumar, Pravir Kumar, R. K. Ambasta, 2018, Briefings in functional genomics.

Ion Channels in Neurological Disorders.

N. Jha, Dhiraj Kumar, Pravir Kumar, 2016, Advances in protein chemistry and structural biology.

Identification and Screening of Novel ACE Inhibitors using Computational Approach

Pravir Kumar, Murali Mohan Mishra, 2023, 2023 3rd International Conference on Intelligent Communication and Computational Techniques (ICCT).

Comparative study of anti-angiogenic activities of luteolin, lectin and lupeol biomolecules

N. Jha, Dhiraj Kumar, Pravir Kumar, 2015, Journal of Translational Medicine.

Computational Analysis Indicates That PARP1 Acts as a Histone Deacetylases Interactor Sharing Common Lysine Residues for Acetylation, Ubiquitination, and SUMOylation in Alzheimer’s and Parkinson’s Disease

Pravir Kumar, Rohan Gupta, 2021, ACS omega.

Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy.

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2023, Biochimica et biophysica acta. Reviews on cancer.

Artificial intelligence and machine learning in precision medicine: A paradigm shift in big data analysis.

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2022, Progress in molecular biology and translational science.

Pravir Kumar, Rohan Gupta, Vaibhav Oli, 2021, Journal of Chemical Neuroanatomy.

No 2 p 38 MAPK and PI 3 K / AKT Signalling Cascades in Parkinson ’ s Disease

N. Jha, Pravir Kumar, R. K. Ambasta, 2019 .

Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder

Pravir Kumar, R. K. Ambasta, Harleen Kohli, 2017, Journal of Translational Medicine.

Aβ, Tau, and α-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides

Dhiraj Kumar, Pravir Kumar, 2019, Neuropeptides.

MOLECULAR DOCKING STUDY OF NEUROPROTECTIVE PLANT-DERIVED BIOMOLECULES IN PARKINSON’S DISEASE

Pravir Kumar, S. Jha, 2017 .

Quercetin mediated reduction of angiogenic markers and chaperones in DLA-induced solid tumours.

P. Asthana, Pravir Kumar, R. K. Ambasta, 2011, Asian Pacific journal of cancer prevention : APJCP.

Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2023, Molecular Neurobiology.

Fate of Jeratinine E as a potential compound to target NNMT protein in countering Parkinson’s disease

Pravir Kumar, Kumud Kaul, 2023, 2023 2nd International Conference on Smart Technologies and Systems for Next Generation Computing (ICSTSN).

AN IN SILICO STUDY OF NARINGENIN-MEDIATED NEUROPROTECTION IN PARKINSON’S DISEASE

Pravir Kumar, S. Jha, 2017 .

New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson’s disease

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2023, Ageing Research Reviews.

Comparative evaluation of 99mTc-MBIP-X/11[C] MBMP for visualization of 18 kDa translocator protein

Pravir Kumar, A. Tiwari, N. Kumari, 2019, New Journal of Chemistry.

Design, synthesis and biological evaluation of methyl-2-(2-(5-bromo benzoxazolone)acetamido)-3-(1H-indol-3-yl)propanoate: TSPO ligand for SPECT

Pravir Kumar, A. Tiwari, H. Ojha, 2016 .

Precision Oncology, Signaling and Anticancer Agents in Cancer Therapeutics.

Pravir Kumar, R. K. Ambasta, S. Kumari, 2021, Anti-cancer agents in medicinal chemistry.

Histone Deacetylase 6 as A Putative Target in Alzheimer’s Disease Therapeutics

Pravir Kumar, S. Shrivastav, 2023, 2023 International Conference on Applied Intelligence and Sustainable Computing (ICAISC).

Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer's and Parkinson's diseases.

Pravir Kumar, Rahul Tripathi, 2023, Integrative biology : quantitative biosciences from nano to macro.

Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics

Pravir Kumar, D. Yadav, 2022, Neurochemistry International.

Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment

Pravir Kumar, Smita Kumari, 2023, Frontiers in Cell and Developmental Biology.

Crocin: A Potent Secondary Metabolite As BACE1 Inhibitor In Alzheimer’s Disease

Pravir Kumar, Murali Mohan Mishra, 2023, 2023 9th International Conference on Advanced Computing and Communication Systems (ICACCS).

NEUROPROTECTIVE ROLE OF BIMOCLOMOL IN ECTOPIC CELL CYCLE IN PARKINSON’S DISEASE: NEW INSIGHTS

Pravir Kumar, Renubala Sharma, 2017 .

Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.

N. Jha, Dhiraj Kumar, Pravir Kumar, 2015, Journal of Alzheimer's disease : JAD.

Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme.

Pravir Kumar, R. K. Ambasta, Rohan Gupta, 2023, Biochimica et biophysica acta. Reviews on cancer.

Rotenone-induced parkinsonism elicits behavioral impairments and differential expression of parkin, heat shock proteins and caspases in the rat

Pravir Kumar, R. K. Ambasta, K. Anand, 2012, Neuroscience.

Triaging between post-translational modification of cell cycle regulators and their therapeutics in neurodegenerative diseases

Pravir Kumar, R. K. Ambasta, Mehar Sahu, 2023, Ageing Research Reviews.

Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis.

K. Walsh, Ling Zeng, Han-Kyu Lee, 2014, Human molecular genetics.

Deciphering the microbial map and its implications in the therapeutics of neurodegenerative disorder

Pravir Kumar, R. K. Ambasta, Shrutikirti Vashishth, 2024, Ageing Research Reviews.

Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer

Pravir Kumar, R. K. Ambasta, Aastha Kaushik, 2024, Ageing Research Reviews.

Huntington's Disease Biomarker Discovery: A Computational Approach

Pravir Kumar, Jasmeer Singh Kalra, 2023, 2023 5th International Conference on Inventive Research in Computing Applications (ICIRCA).

Overview of pro-inflammatory and pro-survival components in neuroinflammatory signalling and neurodegeneration

Pravir Kumar, R. K. Ambasta, Shefali Kardam, 2024, Ageing Research Reviews.